Clinical Trial

Resilience Enhancement Using Electronic Frailty Index-Directed Care Pathway

Recruiting
View on ClinicalTrials.gov →
Summary
The study purpose is to gain a better understanding of the needs of adults aged 65 and older while they are receiving chemotherapy by measuring their resilience and tailor care plans based on their individual needs.
Protocol Amendment History 1 change
critical Recruitment opened 2026-05-07
Trial Details
NCT Number NCT07175376
Lead Sponsor Wake Forest University Health Sciences
Collaborators: Atrium Health Wake Forest Baptist, National Cancer Institute (NCI)
Conditions Cancer, Frail, Chemotherapy
Enrollment 32 participants
Start Date 2026-03-16
Primary Completion 2027-01 (estimated)
Study Completion 2027-05 (estimated)
Updated on ClinicalTrials.gov 2026-07-02